Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors

BMC Cancer

Table 7 Odds ratios and 95% confidence intervals for association of number of metabolic comorbidities with risk of recurrent metastatic disease in overall patients, Luminal B-like subtypes, and post-menopausal women

Number of metabolic comorbidities	Overall (N = 1081)			Luminal B (N = 123)			Post menopause (N = 775)
Number of metabolic comorbidities	OR	95%CI	P value	OR	95%CI	P value	OR	95%CI	P value
0	ref	ref		ref	ref	ref	ref	ref
1	0.795	0.537–1.177	0.252	1.806	0.486–6.703	0.377	0.923	0.566–1.506	0.748
2	1.751	1.137–2.695	0.011	1.230	0.281–5.376	0.783	1.712	1.003–2.924	0.049
3+	1.647	1.139–2.382	0.008	6.500	2.090–20.216	0.001	2.000	1.035–3.067	0.001

ISSN: 1471-2407